Cargando…

Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway

BACKGROUND: Kai-Xin-San (KXS) has been reported to have a good curative impact on dementia. The purpose of the study was to determine whether KXS might ameliorate cognitive deficits in APP/PS1 mice and to evaluate its neuroprotective mechanism. METHODS: APP/PS1 mice were employed as an AD animal mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, ShiJie, Chen, Gongcan, Gao, Minghuang, Zhong, Guangcheng, Zhang, Zerong, Wei, Dongyun, Luo, Xue, Wang, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012453/ https://www.ncbi.nlm.nih.gov/pubmed/36918872 http://dx.doi.org/10.1186/s13020-023-00722-y

Ejemplares similares

Kai Xin San ameliorates scopolamine-induced cognitive dysfunction
por: Xu, Yu-Min, et al.
Publicado: (2019)

Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
por: Luo, Yunxia, et al.
Publicado: (2020)

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer’s disease
por: Luo, Yunxia, et al.
Publicado: (2023)

Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats
por: Dong, X.Z., et al.
Publicado: (2017)

Study on the Multitarget Synergistic Effects of Kai-Xin-San against Alzheimer's Disease Based on Systems Biology
por: Guo, Sirui, et al.
Publicado: (2019)

Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice
por: Jiao, Ya-Nan, et al.
Publicado: (2022)

Classic Prescription, Kai-Xin-San, Ameliorates Alzheimer's Disease as an Effective Multitarget Treatment: From Neurotransmitter to Protein Signaling Pathway
por: Guo, Sirui, et al.
Publicado: (2019)

Behavioral and biochemical effects of a formulation of the traditional Chinese medicine, Kai-Xin-San, in fatigued rats
por: HU, YUAN, et al.
Publicado: (2013)

Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease
por: Yi, Pengji, et al.
Publicado: (2020)

Kai-Xin-San, a Chinese Herbal Decoction, Accelerates the Degradation of β-Amyloid by Enhancing the Expression of Neprilysin in Rats
por: Wang, Na, et al.
Publicado: (2020)

Neuroprotective mechanism of Kai Xin San: upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation
por: Wang, Na, et al.
Publicado: (2017)

Identification of protein targets for the antidepressant effects of Kai-Xin-San in Chinese medicine using isobaric tags for relative and absolute quantitation
por: Dong, Xian-Zhe, et al.
Publicado: (2019)

Kai-Xin-San Protects Depression Mice Against CORT-Induced Neuronal Injury by Inhibiting Microglia Activation and Oxidative Stress
por: Bai, Guiqin, et al.
Publicado: (2022)

MiR-1281 is involved in depression disorder and the antidepressant effects of Kai-Xin-San by targeting ADCY1 and DVL1
por: Chen, Chao, et al.
Publicado: (2023)

A Comparative Study of Serum Pharmacochemistry of Kai-Xin-San in Normal and AD Rats Using UPLC-LTQ-Orbitrap-MS
por: Yang, Lin, et al.
Publicado: (2022)

Kai-Xin-San, a traditional Chinese medicine formulation, exerts antidepressive and neuroprotective effects by promoting pCREB upstream pathways
por: Dong, Xian-Zhe, et al.
Publicado: (2016)

Jia-Wei-Kai-Xin-San Treatment Alleviated Mild Cognitive Impairment through Anti-Inflammatory and Antiapoptotic Mechanisms in SAMP8 Mice
por: Zhang, Xiaolu, et al.
Publicado: (2023)

Kai-Xin-San series formulae alleviate depressive-like behaviors on chronic mild stressed mice via regulating neurotrophic factor system on hippocampus
por: Zhu, Yue, et al.
Publicado: (2017)

A Chinese herbal decoction, reformulated from Kai-Xin-San, relieves the depression-like symptoms in stressed rats and induces neurogenesis in cultured neurons
por: Yan, Lu, et al.
Publicado: (2016)

Kai-Xin-San Attenuates Doxorubicin-Induced Cognitive Impairment by Reducing Inflammation, Oxidative Stress, and Neural Degeneration in 4T1 Breast Cancer Mice
por: Lyu, Wenjiao, et al.
Publicado: (2021)

A Standardized Chinese Herbal Decoction, Kai-Xin-San, Restores Decreased Levels of Neurotransmitters and Neurotrophic Factors in the Brain of Chronic Stress-Induced Depressive Rats
por: Zhu, Kevin Yue, et al.
Publicado: (2012)

SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer's disease
por: Lee, Junghee, et al.
Publicado: (2017)

A Modified Chinese Herbal Decoction (Kai-Xin-San) Promotes NGF-Induced Neuronal Differentiation in PC12 Cells via Up-Regulating Trk A Signaling
por: Yan, Lu, et al.
Publicado: (2017)

Kai-Xin-San, a Chinese Herbal Decoction Containing Ginseng Radix et Rhizoma, Polygalae Radix, Acori Tatarinowii Rhizoma, and Poria, Stimulates the Expression and Secretion of Neurotrophic Factors in Cultured Astrocytes
por: Zhu, Kevin Yue, et al.
Publicado: (2013)

Shikonin Ameliorates LPS-Induced Cardiac Dysfunction by SIRT1-Dependent Inhibition of NLRP3 Inflammasome
por: Guo, Tao, et al.
Publicado: (2020)

Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension
por: Dikalov, Sergey, et al.
Publicado: (2022)

Jia-Wei-Kai-Xin-San, an Herbal Medicine Formula, Ameliorates Cognitive Deficits via Modulating Metabolism of Beta Amyloid Protein and Neurotrophic Factors in Hippocampus of Aβ(1-42) Induced Cognitive Deficit Mice
por: Zhu, Yue, et al.
Publicado: (2019)

Chinese Medicine Formula Kai-Xin-San Ameliorates Neuronal Inflammation of CUMS-Induced Depression-like Mice and Reduces the Expressions of Inflammatory Factors via Inhibiting TLR4/IKK/NF-κB Pathways on BV2 Cells
por: Qu, Suchen, et al.
Publicado: (2021)

Synechocystis KaiC3 Displays Temperature- and KaiB-Dependent ATPase Activity and Is Important for Growth in Darkness
por: Wiegard, Anika, et al.
Publicado: (2020)

SIRT3 deficiency-induced mitochondrial dysfunction and inflammasome formation in the brain
por: Tyagi, Alpna, et al.
Publicado: (2018)

The Use of San-Huang-Xie-Xin-Tang Reduces the Mortality Rate among Breast Cancer Patients
por: Winardi, Daniel, et al.
Publicado: (2023)

Involvement of the SIRT1-NLRP3 pathway in the inflammatory response
por: Chen, Huiyue, et al.
Publicado: (2023)

Age‐dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution
por: Adjei‐Mosi, Jennifer, et al.
Publicado: (2023)

Xin hua jing /
Publicado: (1982)

Neuroprotective Effects of San-Huang-Xie-Xin-Tang in the MPP(+)/MPTP Models of Parkinson's Disease In Vitro and In Vivo
por: Lo, Yi-Ching, et al.
Publicado: (2012)

Mitochondrial dysfunction in hearing loss: Oxidative stress, autophagy and NLRP3 inflammasome
por: Li, Peipei, et al.
Publicado: (2023)

Kai 1 and Kai 2: Characterization of these dog erythrocyte antigens by monoclonal antibodies
por: Lee, Jae Ho, et al.
Publicado: (2017)

Slow and temperature-compensated autonomous disassembly of KaiB–KaiC complex
por: Simon, Damien, et al.
Publicado: (2022)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer’s disease
por: Cummings, Jeffrey L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qmrlag7bddsjvabqnustnm1vlj